You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
眾生藥業(002317.SZ):華南藥業的羧甲司坦片通過仿製藥質量和療效一致性
格隆匯 04-13 20:33

格隆匯4月13日丨眾生藥業(002317.SZ)公佈,近日,廣東眾生藥業股份有限公司全資子公司廣東華南藥業集團有限公司(簡稱“華南藥業”)收到國家藥品監督管理局批准簽發的《藥品補充申請批准通知書》,通知書編號:2022B01466。

羧甲司坦是臨牀常用的黏痰溶解劑,在國內主要用於治療慢性支氣管炎、支氣管哮喘等疾病引起的痰液粘稠、咳痰困難患者。司坦類黏液調節劑能增加黏膜纖毛的轉運,從而增加痰液的排出,有利於起到止咳和消除呼吸道阻塞作用。改善呼吸道分泌細胞的功能,修復黏膜和促進氣管分泌。

羧甲司坦片是我國國家基本藥物目錄藥品和國家醫保目錄藥品。米內網中國城市公立醫院化學藥終端競爭格局數據庫顯示,羧甲司坦片2018至2020年銷售額分別為人民幣3110萬元,4790萬元,5655萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account